Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.10.0.1
Condensed Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2018
Sep. 30, 2018
Current assets    
Cash $ 324,300 $ 597,268
Receivable from related party 4,063 6,229
Prepaid expenses 93,023 110,439
Total current assets 421,386 713,936
Cash and marketable securities held in Trust Account 145,448,268 144,964,309
Interest receivable on cash and marketable securities held in Trust Account 262,269 221,157
TOTAL ASSETS 146,131,923 145,899,402
Current liabilities    
Accounts payable 1,241,371 64,581
Accrued liabilities   772,840
Other current liabilities 214,539 221,865
Total current liabilities 1,455,910 1,059,286
Commitments and contingencies (Note 5)
Common stock subject to possible redemption, 14,292,807 and 14,309,217 shares as of December 31, 2018 and September 30, 2018, respectively, at a redemption value of $10.00 per share 139,676,012 139,840,115
Stockholders’ equity    
Preferred stock, par value of $0.0001 per share; 1,000,000 shares authorized; none issued or outstanding
Common stock, par value of $0.0001 per share; 100,000,000 shares authorized; 4,169,199 and 4,152,789 shares issued and outstanding as of December 31, 2018 and September 30, 2018 (excluding 14,292,807 and 14,309,217 shares subject to possible redemption as of December 31, 2018 and September 30, 2018, respectively) 417 415
Additional paid-in capital 5,829,072 5,664,971
Accumulated deficit (829,488) (665,385)
Total stockholders’ equity 5,000,001 5,000,001
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 146,131,923 $ 145,899,402